BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn FDA moves toward easing restrictions on certain peptides BioPharma Dive When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions BPC 157 Banned: Key Facts on the Latest FDA Decision FDA Moves on Peptides: What Compounding Pharmacies Need to Know We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines